pillbase.ru

Xultophy

Active substance: insulin degludec, liraglutide

insulin degludec, liraglutide

Centralised EU authorisationActive

Marketing holder: Novo Nordisk A/S

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Products containing Insulin degludec in other countries

Showing products with this active substance, combinations included; the full composition is shown for each product.

CountryProducts
US 11
  • Insulin Degludec
    INJECTION, SOLUTION · INSULIN DEGLUDEC 100 U/mL
    50090-7176
    A-S Medication Solutions
  • Insulin Degludec
    INJECTION, SOLUTION · INSULIN DEGLUDEC 200 U/mL
    50090-7175
    A-S Medication Solutions
  • TRESIBA
    INJECTION, SOLUTION · INSULIN DEGLUDEC 200 U/mL
    50090-7094
    A-S Medication Solutions
  • Tresiba
    INJECTION, SOLUTION · INSULIN DEGLUDEC 200 U/mL
    0169-2550
    Novo Nordisk
  • Tresiba
    INJECTION, SOLUTION · INSULIN DEGLUDEC 100 U/mL
    0169-2662
    Novo Nordisk
All products in this country (11)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-2e97-715a-8b92-275e5f9a49e1,01a1208e-40ba-7221-989e-20443fff7f6a,01a1208e-5cb6-7a8c-b0a3-10f6a611c65f,01a1208f-abd6-7a28-9a18-ce1409399a9d,01a12093-88fb-74f4-888d-7b131cb75f5d;count=10 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/002647
Registration status
Active
ATC code
A10AE56
Sources
  • product · EMA · EMEA/H/C/002647 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/002647 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/002647 · Verified 2026-10-09
  • ingredients.1 · EMA · EMEA/H/C/002647 · Verified 2026-10-09